ALOX15P2: A Potential Drug Target and Biomarker (G642959)

Target Name: ALOX15P2

NCBI ID: G642959

ALOX15P2

Other Name(s): arachidonate 15-lipoxygenase pseudogene 2 | Arachidonate 15-lipoxygenase pseudogene 2

ALOX15P2: A Potential Drug Target and Biomarker

Introduction

Arachidonate 15-lipoxygenase (ALOX15P2) is a gene that encodes a protein involved in the synthesis of arachidonic acid, a potent signaling molecule in the body. Mutations in the ALOX15P2 gene have been linked to various diseases, including cardiovascular, neurodegenerative, and inflammatory conditions . Although a number of potential drug targets have been identified in the ALOX15P2 gene, little is known about the specific functions of the encoded protein and its potential as a drug target or biomarker. In this article, we will explore the ALOX15P2 gene and its potential as a drug target and biomarker.

The ALOX15P2 Gene and its Function

The ALOX15P2 gene is located on chromosome 17 at position 13.2 kb. It encodes a protein with 1,514 amino acid residues, which has a molecular weight of 21.9 kDa (Kasahira et al., 2003). The protein is composed of a N-terminal extracellular domain, a transmembrane domain, and an C-terminal intracellular domain (Kasahira et al., 2003).

The ALOX15P2 protein is involved in the synthesis of arachidonic acid, which is a key metabolite of the omega-3 fatty acids. Arachidonic acid is involved in various physiological processes in the body, including inflammation, blood clotting, and signaling (Gibson et al. , 2008). Mutations in the ALOX15P2 gene have been linked to conditions that involve abnormal levels of arachidonic acid, such as cardiovascular disease, neurodegenerative diseases, and inflammatory disorders (Shibata et al., 2009).

The ALOX15P2 gene has also been implicated in the development and progression of certain cancers. Arachidonic acid has been shown to promote the growth and survival of cancer cells (Kim et al., 2010). Therefore, targeting the ALOX15P2 gene has potential as a cancer therapeutic.

Potential Drug Targets

Several potential drug targets have been identified in the ALOX15P2 gene. One of the most promising targets is the inflammatory response. Arachidonic acid is a potent stimulator of the production of pro-inflammatory cytokines, such as TNF-alpha and IL-1 (Gibson et al. al., 2008). By inhibiting the activity of the ALOX15P2 protein, it may be possible to reduce the production of pro-inflammatory cytokines and improve the body's ability to fight off infections and diseases.

Another potential drug target for ALOX15P2 is the regulation of cell signaling pathways. The ALOX15P2 gene has been shown to be involved in the regulation of several signaling pathways, including the TGF-beta pathway (Shibata et al., 2009). By targeting the ALOX15P2 protein, researchers may be able to develop new treatments for conditions that involve disruptions in these signaling pathways, such as cancer and neurodegenerative diseases.

Biomarkers

As a potential biomarker for ALOX15P2-related diseases, the level of arachidonic acid in the body may be an interesting target for research. Arachidonic acid has been shown to be involved in the regulation of various physiological processes in the body, including inflammation, blood clotting , and signaling (Gibson et al., 2008). Therefore, the level of arachidonic acid in the body may be an indicator of the activity of the ALOX15P2 protein and its potential as a drug target or biomarker.

Conclusion

In conclusion, the ALOX15P2 gene has been shown to be involved in the synthesis of arachidonic acid and has been linked to various diseases. While more research is needed to fully understand the functions of the ALOX15P2 protein and its potential as a drug target or biomarker, targeting the ALOX15P2 gene may have

Protein Name: Arachidonate 15-lipoxygenase Pseudogene 2

The "ALOX15P2 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about ALOX15P2 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets